Skip to Main Content




Staphylococcus aureus secretes pore-forming leukocidins that kill leukocytes as part of the bacterium’s evasion strategy. Leukocidin-based vaccination results in toxin-neutralizing antibodies and toxin-specific CD4 lymphocytes that block the toxins and boost host-mediated antimicrobial responses to protect mice from bloodstream infection.

BACH2 is repurposed following Treg lineage commitment to promote the functional quiescence and long-term maintenance of rTreg cells by restraining TCR-driven aTreg differentiation programs. This function is required for immune homeostasis and durable immunosuppressive responses in cancer.

Mailhot et al. show that the cytokine IL-1β directly modulates pain in animal models of chronic inflammatory diseases such as multiple sclerosis, rheumatoid arthritis, and osteoarthritis through a novel subclass of IL-1R1+ nociceptors.

Lee et al. show that circulating NS1 protein does not contribute to dengue pathogenesis in mice infected with highly virulent DENV2 strains. Instead, structural prME region is found to play a critical role in the in vivo fitness and virulence of these strains.

A CpG-stimulated autologous tumor cell vaccine for patients with MCL is safe and feasible and induces detectable antitumor T cell immune responses. Patients who received the CpG-MCL vaccination demonstrated freedom from MRD at 1 yr after ASCT that surpassed previously reported rates.

The C-type lectin layilin has been observed in several human cancers, but its function on immune cells is unknown. This study demonstrates that layilin is highly expressed on clonally expanded CD8+ T cells in human melanoma and augments integrin-mediated cellular adhesion to enhance antitumor immunity.

Chen et al. show that Japanese encephalitis virus (JEV)–elicited CD8+ T cells and antibodies play protective and pathogenic roles in Zika virus–infected wild-type C57BL/6 mice, respectively, and JEV-elicited CD8+ T cells abrogate anti-JEV antibody–mediated enhancement of Zika virus infection in mice.

Uncovering mechanisms that drive pancreatic cancer could lead to effective therapies for this lethal disease. This study reveals how pancreatic cancer cells hyperactivate a pathway to sustain their proliferation. Inhibiting this pathway affects cancer cells, but not normal cells, highlighting a new therapeutic opportunity.

Erythroid progenitors preferentially express ST2, the receptor for IL-33; this cytokine is necessary and sufficient to cause anemia during chronic inflammation. IL-33 directly inhibits differentiation of erythroid progenitors by activating NF-κB signaling, which is normally downregulated in erythropoiesis.

Pancreatic ductal adenocarcinoma (PDAC) cells rely heavily on glutamine metabolism. Recouvreux et al. demonstrate that nutrient stress caused by glutamine deprivation drives epithelial-mesenchymal transition (EMT) and aggressive behaviors in PDAC cells through up-regulation of the EMT master regulator Slug.

The mechanisms that regulate V(D)J recombination to ensure antigen receptor allelic exclusion are poorly understood. The authors show that poor quality Vβ recombination signal sequences stochastically restrict the incidence of Vβ rearrangements to enforce TCRβ allelic exclusion.

Wang et al. demonstrate that a mAb specific for the human microglial receptor TREM2 induces microglia proliferation, ameliorates Aβ-induced pathology in a mouse model of Alzheimer’s disease, and can be given safely in a first-in-human phase I clinical trial.

Brief Definitive Report

How memory Th2 cell subsets orchestrate allergic airway inflammation remains unclear. Rahimi et al. demonstrate that tissue-resident and circulating memory Th2 cells are functionally and transcriptionally distinct subsets with unique roles in promoting allergic airway disease.

Pallett et al. identify mononuclear phagocyte and T cell subsets able to reside in the human liver for over a decade, probing their retention and replenishment using HLA-mismatched allografts and hepatic venous sampling.

Close Modal
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close Modal
Close Modal